drugset / Trial / NCT05565768
Study to Evaluate HZN-457 in Healthy Volunteers
RandomizedSequentialDouble-blindOther
Summary
The purpose of this first in human study is to assess safety, pharmacokinetics, pharmacodynamics, and immunogenicity of single ascending doses of HZN-457.
Timeline
- Start
- 2022-11-22
- Primary completion
- 2023-08-09
- Completion
- 2023-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HZN-457 | Unknown | — | Subcutaneous |
Indications
No indication recorded.